UBE2I Antikörper (AA 33-158)

Produktnummer ABIN7441193

Produktdetails anti-UBE2I Antikörper

Target: UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))

Bindungsspezifität: AA 33-158

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UBE2I Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Verwendungszweck: Polyclonal Antibody to Ubiquitin Conjugating Enzyme E2I (UBE2I)

Spezifität: The antibody is a rabbit polyclonal antibody raised against UBE2I. It has been selected for its ability to recognize UBE2I in immunohistochemical staining and western blotting.

Kreuzreaktivität: Maus, Schwein, Ratte

Aufreinigung: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogen: Recombinant Ubiquitin Conjugating Enzyme E2I (UBE2I) corresdonding to Asp33~Ser158 with N-terminal His Tag

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western blotting: 0.5-2 μg/mL

Immunohistochemistry: 5-20 μg/mL

Immunocytochemistry: 5-20 μg/mL

Optimal working dilutions must be determined by end user.

Kommentare:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Haltbarkeit: 24 months

Details zu UBE2I

Target: UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))

Andere Bezeichnung: Ubiquitin Conjugating Enzyme E2I (UBE2I Produkte)

Synonyme: C358B7.1 antikoerper, P18 antikoerper, UBC9 antikoerper, ubc9 antikoerper, ube2ia antikoerper, zUbc9 antikoerper, 5830467E05Rik antikoerper, F830028O17Rik antikoerper, Ubce2i antikoerper, Ubce9 antikoerper, UbcE2A antikoerper, ubce9 antikoerper, T13J8.70 antikoerper, T13J8_70 antikoerper, UBIQUITIN-PROTEIN LIGASE antikoerper, ubiquitin conjugating enzyme 9 antikoerper, ubiquitin conjugating enzyme E2 I antikoerper, ubiquitin-conjugating enzyme E2Ib antikoerper, ubiquitin-conjugating enzyme E2L antikoerper, ubiquitin-conjugating enzyme E2I antikoerper, ubiquitin conjugating enzyme E2I S homeolog antikoerper, ubiquitin conjugating enzyme 9 antikoerper, SUMO-conjugating enzyme UBC9 antikoerper, UBE2I antikoerper, ube2ib antikoerper, UBE2L antikoerper, Ube2i antikoerper, ube2i.S antikoerper, UBC9 antikoerper, ubc-9 antikoerper, LOC108703134 antikoerper

Hintergrund: P18, UBC9, UBCE9, SUMO-protein ligase, Ubiquitin carrier protein 9, Ubiquitin carrier protein I, Ubiquitin-protein ligase I, SUMO-conjugating enzyme UBC9

Pathways: Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Ubiquitin Proteasome Pathway